Many patients with SARS-CoV-2 infection have underlying chronic medical conditions. |
Patient-related outcomes are worse if there are associated comorbidities. |
Insulin resistance and cardiovascular disease contribute to the increased severity of COVID-19. |
Management of dysglycemia, hypertension, and dyslipidemia should be targeted individually in patients with COVID-19 infection. |
SARS-CoV-2 patients are vulnerable to the development of thromboembolic disease. A personalized approach to antithrombotic/thromboembolism prophylaxis is recommended. |
Open Access 06.07.2020 | COVID-19 | Review
Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature
Erschienen in: Advances in Therapy | Ausgabe 8/2020